Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhalation Approaches to Nausea
NCT04181463Phase 2Not yet recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Isopropyl alcohol in nausea ((none)), sponsored by University of Texas MD Anderson Cancer Center. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
Isopropyl alcohol
03
Conditions
nausea ((none))
Beyond the preview
Go deeper on NCT04181463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04181463.